Jun Luo

Jun Luo

Auto-generated profile, based on publicly available information

Jun Luo

Rosalind and Morris Goodman Cancer Institute, McGill University, Montréal, QC H3A 1A3, Canada

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Molecular Cell
Verified
Journal Article
Closed access
XZXu Zhang
Xu Zhang
CCClément Chapat
Clément Chapat
PWPeng Wang
Peng Wang
JCJung-Hyun Choi
Jung-Hyun Choi
QLQian Li
Qian Li
NSNahum Sonenberg
Nahum Sonenberg

19 July 2024 in Science Advances
Verified
Journal Article
Open access
JCJung-Hyun Choi
Jung-Hyun Choi
JLJun Luo
Jun Luo
GHGeoffrey G. Hesketh
Geoffrey G. Hesketh
SGShuyue Guo
Shuyue Guo
APAngelos Pistofidis
Angelos Pistofidis
SJSeyed Mehdi Jafarnejad
Seyed Mehdi Jafarnejad
Viruses can selectively repress the translation of mRNAs involved in the antiviral response. RNA viruses exploit the Grb10-interacting GYF (glycine-tyrosine-phenylalanine) proteins 2 (GIGYF2) and eukaryotic translation initiation factor 4E (eIF4E) homologous protein 4EHP to selectively repress the translation of transcripts such as Ifnb1 , which encodes the antiviral cytokine interferon-β (IFN-β). Herein, we reveal that GIGYF1, a paralog of GIGYF2, robustly represses cellular mRNA translation through a distinct 4EHP-independent mechanism. Upon recruitment to a target mRNA, GIGYF1 binds to subunits of eukaryotic translation initiation factor 3 (eIF3) at the eIF3-eIF4G1 interaction interface. This interaction disrupts the eIF3 binding to eIF4G1, resulting in transcript-specific translational repression. Depletion of GIGYF1 induces a robust immune response by derepressing IFN-β production. Our study highlights a unique mechanism of translational regulation by GIGYF1 that involves sequestering eIF3 and abrogating its binding to eIF4G1. This mechanism has profound implications for the host response to viral infections.